Literature DB >> 12761165

Significant reduction of WT1 gene expression, possibly due to epigenetic alteration in Wilms' tumor.

Yuji Satoh1, Tetsuji Nakagawachi, Hisaya Nakadate, Yasuhiko Kaneko, Zenjiro Masaki, Tsunehiro Mukai, Hidenobu Soejima.   

Abstract

WT1 at 11p13 is a tumor suppressor gene, an aberration of which causes Wilms' tumor (WT). Since WT1 expression is reduced in a certain proportion of WTs and its mutation is found only in 10-20% of WTs, we examined WT1 gene silencing due to epigenetic alteration in a total of 22 WTs. WT1 expression was significantly reduced in half of WTs without any mutation in the WT1 gene itself, suggesting that the reduction of expression was possibly epigenetic. We found promoter hypermethylation in one WT with loss of heterozygosity (LOH) and showed that promoter methylation reduced reporter gene activity by a reporter assay. These data suggested that methylation was an epigenetic mechanism leading to WT1 silencing and that the expression-reduced allele by hypermethylation combined with LOH was consistent with the revised two-hit model. In addition, as the beta-catenin mutation is frequently associated with the WT1 mutation, the association of WT1 silencing with the beta-catenin mutation was also investigated. beta-catenin mutated in only one WT without WT1 silencing, suggesting that the beta-catenin mutation was not associated with the reduction of WT1 expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761165     DOI: 10.1093/jb/mvg041

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  7 in total

1.  Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (WT1) promotes cell proliferation: implication for cancer therapeutics.

Authors:  Mohammad Iqbal Rather; Shivananda Swamy; Kodaganur S Gopinath; Arun Kumar
Journal:  J Biol Chem       Date:  2013-11-20       Impact factor: 5.157

2.  Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis.

Authors:  Ie-Ming Shih; Li Chen; Chen C Wang; Jinghua Gu; Ben Davidson; Leslie Cope; Robert J Kurman; Jianhua Xuan; Tian-Li Wang
Journal:  Am J Obstet Gynecol       Date:  2010-10-20       Impact factor: 8.661

3.  Characterizing DNA methylation patterns in pancreatic cancer genome.

Authors:  Aik Choon Tan; Antonio Jimeno; Steven H Lin; Jenna Wheelhouse; Fonda Chan; Anna Solomon; N V Rajeshkumar; Belen Rubio-Viqueira; Manuel Hidalgo
Journal:  Mol Oncol       Date:  2009-04-22       Impact factor: 6.603

4.  Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.

Authors:  Jian Yu; Hongyu Zhang; Jun Gu; Song Lin; Junhua Li; Wei Lu; Yifei Wang; Jingde Zhu
Journal:  BMC Cancer       Date:  2004-09-14       Impact factor: 4.430

5.  Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours.

Authors:  Y Satoh; H Nakadate; T Nakagawachi; K Higashimoto; K Joh; Z Masaki; J Uozumi; Y Kaneko; T Mukai; H Soejima
Journal:  Br J Cancer       Date:  2006-08-08       Impact factor: 7.640

6.  Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma.

Authors:  S Honda; Y Arai; M Haruta; F Sasaki; M Ohira; H Yamaoka; H Horie; A Nakagawara; E Hiyama; S Todo; Y Kaneko
Journal:  Br J Cancer       Date:  2008-10-28       Impact factor: 7.640

7.  In silico regulatory analysis for exploring human disease progression.

Authors:  Dustin T Holloway; Mark Kon; Charles DeLisi
Journal:  Biol Direct       Date:  2008-06-18       Impact factor: 4.540

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.